Nippon Life Discloses $158M Corebridge Buying Spree Under 10b5-1 Plan
CRBG sits 58% above its 52-week low of $22.19.
Summary
Nippon Life disclosed $158 million of Corebridge purchases over 60 days under a 10b5-1 plan, raising its stake to 28.4% as the Equitable merger nears completion.
Key Events · Ownership and Investor Activity · CRBG
-
Nippon Life Buys $158M of Corebridge
Nippon Life Insurance Company acquired 4,614,523 shares for approximately $158,225,595 between September 9 and October 2, 2026, under a previously disclosed 10b5-1 trading plan.
-
Stake Rises to 28.4%
Aggregate beneficial ownership now stands at 126,604,050 shares, or 28.4% of the 445,772,522 shares outstanding as of July 31, 2026, including 33,271 shares held by subsidiary Nissay Asset Management.
-
Purchases Near 52-Week High
The weighted average prices ranged from $32.78 to $35.20 per share, executed while the stock traded near its 52-week high of $35.64.
-
Pre-Planned, Not Discretionary
All purchases were made under a Rule 10b5-1 plan adopted August 7, 2026, indicating the accumulation was scheduled in advance rather than a reactive buy.
Analysis · CRBG · Finance
Nippon Life Insurance Company, Corebridge's largest shareholder, bought 4.6 million shares for roughly $158 million between September 9 and October 2 under a pre-arranged 10b5-1 trading plan. The purchases lifted its stake to 126.6 million shares, or 28.4% of the company. This is a significant accumulation by a strategic owner, executed at prices between $32.29 and $35.60 — near the stock's 52-week high — and comes amid Corebridge's pending all-stock merger with Equitable, which shareholders approved in late July. The buying is mechanical under the plan adopted August 7, not discretionary, but the scale and timing still matter: a major holder is increasing exposure to the combined company ahead of the merger's completion.
How filings like this one have moved
In the 30 days to Oct 6, 2026, 28.9% of the 1573 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRBG was trading at $35.17 on NYSE in the Finance sector, with a market capitalization of approximately $15.7B. The 52-week trading range was $22.19 to $35.64. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.